Clopidogrel Increases Dasabuvir Exposure With or Without Ritonavir, and Ritonavir Inhibits the Bioactivation of Clopidogrel

Matti K. Itkonen, Aleksi Tornio, Outi Lapatto-Reiniluoto, Mikko Neuvonen, Pertti J. Neuvonen, Mikko Niemi, Janne T. Backman

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråkengelska
TidskriftClinical Pharmacology and Therapeutics
Volym105
Utgåva1
Sidor (från-till)219-228
Antal sidor10
ISSN0009-9236
DOI
StatusPublicerad - jan 2019
MoE-publikationstypA1 Tidskriftsartikel-refererad

Vetenskapsgrenar

  • 317 Farmaci
  • 3111 Biomedicinska vetenskaper

Citera det här

Itkonen, Matti K. ; Tornio, Aleksi ; Lapatto-Reiniluoto, Outi ; Neuvonen, Mikko ; Neuvonen, Pertti J. ; Niemi, Mikko ; Backman, Janne T. / Clopidogrel Increases Dasabuvir Exposure With or Without Ritonavir, and Ritonavir Inhibits the Bioactivation of Clopidogrel. I: Clinical Pharmacology and Therapeutics. 2019 ; Vol. 105, Nr. 1. s. 219-228.
@article{1d087619e813400a89e3e7e65d3bf39d,
title = "Clopidogrel Increases Dasabuvir Exposure With or Without Ritonavir, and Ritonavir Inhibits the Bioactivation of Clopidogrel",
keywords = "DRUG-DRUG INTERACTION, ACTING ANTIVIRAL REGIMEN, PLASMA-CONCENTRATIONS, MARKEDLY INCREASES, CYTOCHROME-P450 3A, PLUS DASABUVIR, PHARMACOKINETICS, OMBITASVIR, PARITAPREVIR/RITONAVIR, PHARMACODYNAMICS, 317 Pharmacy, 3111 Biomedicine",
author = "Itkonen, {Matti K.} and Aleksi Tornio and Outi Lapatto-Reiniluoto and Mikko Neuvonen and Neuvonen, {Pertti J.} and Mikko Niemi and Backman, {Janne T.}",
year = "2019",
month = "1",
doi = "10.1002/cpt.1099",
language = "English",
volume = "105",
pages = "219--228",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Wiley",
number = "1",

}

Itkonen, MK, Tornio, A, Lapatto-Reiniluoto, O, Neuvonen, M, Neuvonen, PJ, Niemi, M & Backman, JT 2019, 'Clopidogrel Increases Dasabuvir Exposure With or Without Ritonavir, and Ritonavir Inhibits the Bioactivation of Clopidogrel', Clinical Pharmacology and Therapeutics, vol. 105, nr. 1, s. 219-228. https://doi.org/10.1002/cpt.1099

Clopidogrel Increases Dasabuvir Exposure With or Without Ritonavir, and Ritonavir Inhibits the Bioactivation of Clopidogrel. / Itkonen, Matti K.; Tornio, Aleksi; Lapatto-Reiniluoto, Outi; Neuvonen, Mikko; Neuvonen, Pertti J.; Niemi, Mikko; Backman, Janne T.

I: Clinical Pharmacology and Therapeutics, Vol. 105, Nr. 1, 01.2019, s. 219-228.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

TY - JOUR

T1 - Clopidogrel Increases Dasabuvir Exposure With or Without Ritonavir, and Ritonavir Inhibits the Bioactivation of Clopidogrel

AU - Itkonen, Matti K.

AU - Tornio, Aleksi

AU - Lapatto-Reiniluoto, Outi

AU - Neuvonen, Mikko

AU - Neuvonen, Pertti J.

AU - Niemi, Mikko

AU - Backman, Janne T.

PY - 2019/1

Y1 - 2019/1

KW - DRUG-DRUG INTERACTION

KW - ACTING ANTIVIRAL REGIMEN

KW - PLASMA-CONCENTRATIONS

KW - MARKEDLY INCREASES

KW - CYTOCHROME-P450 3A

KW - PLUS DASABUVIR

KW - PHARMACOKINETICS

KW - OMBITASVIR

KW - PARITAPREVIR/RITONAVIR

KW - PHARMACODYNAMICS

KW - 317 Pharmacy

KW - 3111 Biomedicine

U2 - 10.1002/cpt.1099

DO - 10.1002/cpt.1099

M3 - Article

VL - 105

SP - 219

EP - 228

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 1

ER -

Itkonen MK, Tornio A, Lapatto-Reiniluoto O, Neuvonen M, Neuvonen PJ, Niemi M et al. Clopidogrel Increases Dasabuvir Exposure With or Without Ritonavir, and Ritonavir Inhibits the Bioactivation of Clopidogrel. Clinical Pharmacology and Therapeutics. 2019 jan;105(1):219-228. https://doi.org/10.1002/cpt.1099

Åtkomst till dokument